Useful Articles - Insurance

Most HMOs require you to select a specific doctor as your primary-care physician

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

. This doctor is supposed to be your first “port-of-call” for most any medical c

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ondition, although exceptions are typically made for emergencies. As such, he o

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

r she will end up providing most of your medical care. Your choice of specialist

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s and hospitals is usually limited to those already under contract with the HMO,

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

and your primary care physician is the one who decides whether or not a referra

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

l to a specialist is actually necessary.

Primary care providers and hospitals i

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

n HMOs are typically paid in advance for a member’s healthcare. Therefore, pat

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ients can make office visits or hospital stays without filling out claim forms.

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

Co-payments and deductibles, however, may still be required.

PPO stands for “

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

Preferred Provider Organization.” PPOs combine some of the characteristics of HM

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

Os with the flexibility of traditional fee-for-service plans.

As with an HMO, P

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

POs offer a specific set of doctors and hospitals that the member can choose fro

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

m to get discounted rates. These are called “preferred” or “in-network” provider

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

s. PPO members are free to see any in-network provider at any time. Members can

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

also see doctors who are not in the network, but the co-insurance payment for th

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ose doctors will be higher.

National survey data from Mercer Human Resources Co

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

nsulting shows that in 2002, 49% of employees in the United States were enrolled

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

in PPO plans. In the same year, 31% of employees were enrolled in HMOs, 14 perc

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ent in so-called “POS” plans, and 6% in indemnity plans with no provider network

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefularticles.org.ua/article/121584/usefularticles-Whats-the-Difference-Between-an-HMO-and-a-PPO.html">What's the Difference Between an HMO and a PPO?</a>

BB link (for phorums):
[url=http://www.usefularticles.org.ua/article/121584/usefularticles-Whats-the-Difference-Between-an-HMO-and-a-PPO.html]What's the Difference Between an HMO and a PPO?[/url]

If professionals know you or your business as a common denominator, you are on your way to successfully branding your business and your reputation.

Wondering whether to bother with the latest offering from Matt Callen, promising to show you how to make more money with Adsense? Read an honest, unbiased view of this 47 page ebook and whether it can help you build an online business.

Tags

Links

Useful Articles - What's the Difference Between an HMO and a PPO?

Related Articles: